<DOC>
	<DOCNO>NCT01028924</DOCNO>
	<brief_summary>The primary objective trial investigate teduglutide effect cardiac repolarisation ( QT , QTc interval ) . Secondary objective investigation possible effect heart rate cardiac conduction ( RR PR interval , QRS duration ) , pharmacokinetics safety tolerability healthy subject , determine effect positive control , moxifloxacin , sensitivity analysis . The trial consist screen treatment phase four treatment period . There washout period least 7 day 4 week maximum administration . The expected total trial duration individual subject 7 week ( maximum 17 ) week .</brief_summary>
	<brief_title>Effects Teduglutide Cardiac Repolarisation Conduction Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female volunteer Normal body weight ( body mass index within â‰¥18 29 kg/m2 ( inclusive ) body weight &gt; 50 kg ( female ) &gt; 60 kg ( male ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Thorough QTc-Study</keyword>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>Cardiac safety</keyword>
</DOC>